NEW
YORK, Aug. 1, 2024 /PRNewswire/ -- The global
digital diabetes management market size is estimated to grow by
USD 19.12 billion from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 21.99% during the forecast period. Rising global
burden of diabetes is driving market growth, with a trend
towards integration of ai in wearable medical devices.
However, stringent regulatory framework in digital diabetes
management poses a challenge. Key market players include
Abbott Laboratories, B.Braun SE, Becton
Dickinson and Co., DarioHealth Corp., Dassault Systemes SE,
decide Clinical Software GmbH, Dexcom Inc., F. Hoffmann La Roche
Ltd., Glooko Inc., GlucoMe Ltd., Informed Data Systems Inc. And
One Drop., Insulet Corp., LifeScan
IP Holdings LLC, Medtronic Plc, Orpyx Medical Technologies Inc.,
PHC Holdings Corp., Sharecare Inc., SOCIALDIABETES SL, Tandem
Diabetes Care Inc., and WaveForm Technologies Inc..
![Technavio has announced its latest market research report titled Global Digital Diabetes Management Market 2024-2028 Technavio has announced its latest market research report titled Global Digital Diabetes Management Market 2024-2028](https://mma.prnewswire.com/media/2472688/20231121125517_bw_info_v4.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Digital Diabetes
Management Market Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
21.99%
|
Market growth
2024-2028
|
USD 19.12
billion
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
21.14
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
46%
|
Key
countries
|
US, Germany, France,
UK, and China
|
Key companies
profiled
|
Abbott Laboratories,
B.Braun SE, Becton Dickinson and Co., DarioHealth Corp., Dassault
Systemes SE, decide Clinical Software GmbH, Dexcom Inc., F.
Hoffmann La Roche Ltd., Glooko Inc., GlucoMe Ltd., Informed Data
Systems Inc. And One Drop., Insulet Corp., LifeScan IP Holdings
LLC, Medtronic Plc, Orpyx Medical Technologies Inc., PHC Holdings
Corp., Sharecare Inc., SOCIALDIABETES SL, Tandem Diabetes Care
Inc., and WaveForm Technologies Inc.
|
Market Driver
The digital diabetes management market is experiencing
significant growth due to increased innovation and technological
advancements. Manufacturers are designing more compact, light, and
ergonomic wearable medical devices using technologies such as
system-on-chip (SoC) and chip-scale package (CSP). Devices like the
MiniMed 670G system and KTrack Glucose offer advanced features,
such as automated insulin delivery and real-time glucose monitoring
on a smartwatch. The FreeStyle Libre system by Abbott, a 14-day
continuous glucose monitoring system, is another example of
technological innovation. The integration of AI into mobile-based
diabetic management and the availability of advanced products have
revolutionized diabetic monitors. Smart wearable diabetic
management systems with wireless technology are becoming
increasingly popular. These advancements are expected to drive the
growth of the global digital diabetes management market during the
forecast period.
Digital diabetes management is a growing market with innovative
trends transforming diabetes care solutions. Apps, cloud-based
enterprise solutions, and AI technology lead the way. AI and
machine learning use algorithms to analyze data from handheld
devices, wearable devices, and smart insulin meters for continuous
glucose monitoring. Insulin delivery devices like smart insulin
pumps, closed-loop pumps, and wearable insulin patches offer
automated insulin delivery and dosing algorithms. Data management
software and big data analytics help healthcare providers monitor
diabetes patients remotely. Obesity management is also a focus with
fitness trackers, wearable medical devices, and smartwatches. Type
1 and Type 2 diabetes patients benefit from exercise guidance,
insulin monitoring, and insulin injection guidance. Digital
technologies are revolutionizing diabetes care, reducing patient
visits, and improving lifestyle patterns.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
- The digital diabetes management market is witnessing
significant growth due to the increasing prevalence of diabetes and
the modernization of medical devices. However, stringent medical
device regulations in both Europe
and the US pose challenges for vendors offering advanced digital
diabetes management devices. The US FDA classifies diabetes care
management devices as Class II, and failure to comply with these
regulations can lead to product recalls, negatively impacting a
company's brand reputation. For instance, F. Hoffmann-La Roche
experienced a recall of its ACCU-CHEK Flex Link Plus infusion sets
due to kinked or bent cannulas, leading to under-delivery of
insulin and potential elevation of blood glucose levels. Vendors
must undergo rigorous postmarket approvals to ensure compliance
with these regulations and maintain patient safety. The regulatory
focus on robust surveillance systems, enhanced postmarket
regulations, and improved monitoring of devices in Europe and the US can potentially hamper
market growth during the forecast period.
- The digital diabetes management market is growing rapidly as
more diabetes patients turn to remote monitoring and digital
technologies for managing their condition. Big data analytics and
AI technology are key drivers, enabling real-time insulin
monitoring, injection guidance, and diabetes prediction. Remote
patient monitoring through wearable medical devices like fitness
trackers, smartwatches, and activity monitors, as well as handheld
devices and smartphone apps, are popular solutions. Hospitals,
diagnostic centers, and home settings are major segments.
Challenges include ensuring accuracy and reliability, integrating
with insulin delivery devices like insulin pens and patches, and
addressing the needs of Type 1 and Type 2 diabetes patients.
Healthcare providers must adapt to these digital solutions to
improve patient outcomes and reduce costs. Digital technologies
like automated insulin delivery and insulin dosing algorithms are
revolutionizing diabetes care, while lifestyle patterns and
pancreas function analysis are essential for effective
management.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This digital diabetes management market report extensively
covers market segmentation by
- End-user
- 1.1 Hospitals
- 1.2 Home settings
- 1.3 Diagnostic centers
- Type
- 2.1 Wearable devices
- 2.2 Hand-held devices
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Hospitals- The hospital segment in digital
diabetes management refers to the utilization of digital tools and
technologies for diabetes management within healthcare facilities.
This segment encompasses mobile applications, online platforms,
electronic health records (EHRs), medical devices, and telehealth
services. Hospitals employ remote patient monitoring through
glucose monitoring devices, enabling continuous blood sugar level
tracking and prompt action. Diabetes education and self-management
resources are provided via interactive tools, mobile apps, and
online courses. EHRs facilitate access to accurate patient data,
enhancing care coordination and reducing medical errors. Telehealth
services offer remote consultations, saving patients time and
money, while medical device integration enables real-time data
collection and analysis. Data analytics and decision support
systems help healthcare professionals identify trends and insights
for personalized treatment plans. By implementing digital
solutions, hospitals enhance patient care, expand access to
healthcare services, and empower patients to actively manage their
diabetes, fueling the growth of the global digital diabetes
management market.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2017-2021) - Download a Sample Report
Research Analysis
Digital diabetes management refers to the use of technology to
help diabetes patients effectively manage their condition. This
includes a range of solutions such as apps, cloud-based enterprise
solutions, and handheld devices. Artificial intelligence (AI) and
machine learning algorithms are increasingly being used to analyze
big data and provide personalized insulin monitoring, diabetes
prediction, exercise guidance, and more. Obesity, a common
comorbidity in diabetes, can also be addressed through digital
solutions that promote healthy lifestyle choices. Remote patient
monitoring allows healthcare providers to keep track of patients'
glucose levels and other vital signs in real-time, whether in
hospitals, diagnostic centers, or home settings. Solutions like
smart insulin pens, insulin pumps, patches, and smartwatches are
making diabetes management more convenient and efficient for
patients. AI technology is also being explored for closed-loop
systems that can automatically adjust insulin doses based on
real-time glucose readings. The geriatric population, a growing
segment of diabetes patients, can particularly benefit from these
digital solutions due to their ease of use and ability to improve
health outcomes.
Market Research Overview
Digital diabetes management refers to the use of technology and
digital health solutions to help diabetes patients effectively
manage their condition. This includes a range of offerings such as
diabetes care apps, cloud-based enterprise solutions, and handheld
devices. Artificial intelligence (AI) and machine learning
algorithms are increasingly being used to analyze patient data,
including glucose levels, lifestyle patterns, and insulin dosing,
to provide personalized insulin monitoring, injection guidance, and
diabetes prediction. Wearable devices like smartwatches, fitness
trackers, and continuous glucose monitoring systems are also
popular in digital diabetes management. Obesity, a common
comorbidity in diabetes, can also be addressed through these
solutions. Digital diabetes management caters to both Type 1 and
Type 2 diabetes patients in various settings, including hospitals,
home settings, and diagnostic centers. Big data analytics and AI
technology enable healthcare providers to remotely monitor patients
and offer timely interventions. Insulin delivery devices, such as
smart insulin pumps, closed-loop pumps, and smart insulin patches,
are also part of the digital diabetes management landscape. Digital
technologies are transforming diabetes care, making it more
accessible, personalized, and effective.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Hospitals
- Home Settings
- Diagnostic Centers
- Type
-
- Wearable Devices
- Hand-held Devices
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/digital-diabetes-management-market-size-is-set-to-grow-by-usd-19-12-billion-from-2024-2028--rising-global-burden-of-diabetes-boost-the-market-technavio-302210982.html
SOURCE Technavio